Search

Your search keyword '"Beatch, A."' showing total 294 results

Search Constraints

Start Over You searched for: Author "Beatch, A." Remove constraint Author: "Beatch, A."
294 results on '"Beatch, A."'

Search Results

1. Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

4. Spontaneous and TMS-related EEG changes as new biomarkers to measure anti-epileptic drug effects

5. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker

6. Interim Long-term Safety and Efficacy of XEN1101, a Potent, Selective Potassium Channel Opener: Update from an Ongoing Open-label Extension of a Phase 2b Study (X-TOLE) in Adults with Focal Epilepsy (S19.005)

7. The Impact of Disease Severity on Responder Rates in a Phase 2b Study of XEN1101, a Potent, Selective Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE) (S19.004)

8. Supreme Court Of Canada Rules That Bill C-92 As A Whole Is Constitutional

9. TMS as a pharmacodynamic indicator of cortical activity of a novel anti‐epileptic drug, XEN1101

10. Financial Markets Data Collection Using the Information Model of Interagency Cooperation and the International System of Codification of Financial Instruments

15. XEN1101, a Novel Potassium Channel Modulator: Interim Data From an Ongoing, Long-Term, Open-Label Extension of a Phase 2b study (X-TOLE) in Adults with Focal Epilepsy (S44.008)

19. Empowering Indigenous Communities: Latest Coordination Agreements Under Bill C-92

20. Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial

21. Cost of climate change mitigation in Canada's forest sector

23. Two More First Nations Sign Historic Coordination Agreements Under Bill C-92 Framework

25. Taking Ownership: The Implementation of a Non-Aboriginal Early Education Programme for on-Reserve Children

27. Phase 2b Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults with Focal Epilepsy (X-TOLE) (P12-8.006)

28. Canadian boreal forests and climate change mitigation

29. Cortical oscillations to measure anti-epileptic drug activity in clinical trials

30. Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker

32. Taking Ownership: The Implementation of a Non-Aboriginal Early Education Programme for On-Reserve Children

39. Cost of climate change mitigation in Canada’s forest sector

40. Children’s understanding of additive concepts

41. Efficacy and Safety of Vernakalant for Cardioversion of Recent-onset Atrial Fibrillation in the Asia–Pacific Region: A Phase 3 Randomized Controlled Trial

46. Magnesium shifts voltage dependence of activation of delayed rectifier IK in guinea pig ventricular myocytes

50. Children's multiplication and division shortcuts: Increasing shortcut use depends on how the shortcuts are evaluated

Catalog

Books, media, physical & digital resources